|
May 15
|
UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down
|
|
May 15
|
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
|
|
May 15
|
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer
|
|
May 15
|
These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now
|
|
May 14
|
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
|
|
May 14
|
Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs
|
|
May 14
|
2 Top Pharma Stocks That Just Keep Getting Better and Better
|
|
May 14
|
Is Eli Lilly's Latest Deal a Gamechanger?
|
|
May 14
|
3 Magnificent Stocks That Are Passive Income Machines
|
|
May 13
|
Wegovy weight loss sustained for four years in trial, Novo Nordisk says
|
|
May 13
|
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
|
|
May 11
|
1 No-Brainer Growth Stock to Buy and Hold
|
|
May 11
|
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
|
|
May 10
|
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
|
|
May 10
|
How A Top Fund Beats The Market By Owning Future Leaders
|
|
May 10
|
Innovent’s mazdutide superior to Trulicity in Phase III T2D trial
|
|
May 10
|
Zacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
|
|
May 10
|
UPDATE 2-India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
|
|
May 9
|
Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled
|
|
May 9
|
3 Stocks to Buy Following Guidance Upgrades
|